Integrating molecular diagnostics into patient care to truly personalize medicine is key to the future of successful medicine, in particular cancer care. That was the message delivered by Reinhard ...
New technologies emerging from the Human Genome Project and the rapidly expanding direct-to-consumer DNA testing have provided a challenging environment for the entry of pharmacogenomics into clinical ...
Local health sciences company Gestalt Diagnostics says it has achieved a significant milestone by using artificial intelligence and digital pathology to improve patient care. BioReference Laboratories ...
Association for Molecular Pathology publishes best practice recommendations for clinical HRD testing
ROCKVILLE, Md. – June 24, 2025 – The Association for Molecular Pathology, the premier global molecular diagnostic professional society, today announced the publication of best practice recommendations ...
ROCKVILLE, Md. – Oct. 12, 2023 – The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today published a set of 13 best practice recommendations ...
Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard ...
Is Independent Clinical Research Possible in Low- and Middle-Income Countries? A Roadmap to Address Persistent and New Barriers and Challenges Multiple barriers to adequate cancer treatment in ...
In early studies, artificial intelligence (AI) has demonstrated promise toward supporting and augmenting clinician-driven cancer diagnosis and prognosis; an example includes the emergence of digital ...
Vision – To be the world's leading and most trusted provider of information and services that will make a real difference in clinical practice and improve outcomes for patients. Mission – To lead the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback